Delivery Order SPE2DB20D3101-SPE2DB23FRSD3

Award Date 7/19/23
Potential Completion Date 7/20/23
Potential Value $1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,183.60, is for the delivery of Anastrozole 1 mg tablets. The contract has an ultimate completion date of December 27, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Anastrozole 1 mg tablets. The $1,650.89 firm-fixed price delivery order is not set aside and has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical through December 2025 for providing a comprehensive...
This federal contract award, valued at $1,214.51, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,832,009 units of the pharmaceutical product Anastrozole 1 mg tablets, to be provided in 90-count bottles. The contract has a performance period ending on January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,548.90, is for the delivery of 4560665798 Anastrozole 1 mg tablets in quantities of 90. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,712.64 for the supply of 4560924625 - Anastrozole 1 mg Tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of May 15, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is a delivery order (SPE2DB24D2205|SPE2DB25FDXBZ) valued at $1,658.78, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Anastrozole 1 mg tablets in 90-count packages, a medication used in the treatment of breast cancer. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,561,502,484 tablets of Anastrozole 1 mg. The contract has a ceiling value of $6,393.88 and a completion date of July 17, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, with a $1,897.37 ceiling value, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4560137029 - ANASTROZOLE 1 MG TABLET 30S. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,175.58 firm fixed-price contract is for the delivery of 4,562,781,280 units of Anastrozole 1 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a $750,000...
This federal contract award, with identification number SPE2DB20D3101|SPE2DB23FRHK8, is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560523322 - Anastrozole 1 mg Tablets, 30s, with a ceiling value of $1,567.44 and a completion date of April 10, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a significant...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRSD3
    Delivery Order

This federal contract award is for the delivery of Anastrozole 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,034.51, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company.

The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's (DoD) and Department of Veterans Affairs' (VA) healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:20 AM